Philip Orlander is an Endocrinology/Metabolic physician affiliated with The University of Texas Health Science Center at Houston. OpenAlex indexes 38 publications with 1,073 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6410 Fannin St
600
Houston, TX 770303000
Telephone
832-325-7161Registry record last updated 11 Feb 2008.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BETA BIONICS, INC.Program year20252 payments
- BETA BIONICS, INC.Program year20241 payment
- Dexcom, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
47.6%Insulin Analog13.6%Lantus Solostar33%Tresiba Flextouch U-10014%Humalog Kwikpen U-10010%Tresiba Flextouch U-2009%Humalog7%Insulin Aspart Flexpen7%Toujeo Solostar5%Basaglar Kwikpen U-1004%Fiasp Flextouch4%Lantus4%Novolog4%Part D<11 patientsGLP-1 receptor agonist12%Mounjaro51%Ozempic49%Part D≥23 patients+ 5 more classes in this area
Cardiovascular
24.2%Statin8.6%Atorvastatin Calcium35%Rosuvastatin Calcium25%Simvastatin24%Pravastatin Sodium16%Part D<11 patientsACE inhibitor4.1%Lisinopril74%Lisinopril-Hydrochlorothiazide14%Ramipril12%Part D<11 patients+ 7 more classes in this area
Hormonal (systemic)
18.3%l-Thyroxine16.1%Levothyroxine Sodium65%Synthroid35%Part D≥62 patientsVasopressin Analog1%Desmopressin Acetate100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- SAT-485 Recurrent Pheochromocytoma and Mediastinal Mass in a Patient with SDHD-Associated Hereditary Paraganglioma-Pheochromocytoma Syndrome
Journal of the Endocrine Society
2025 - SAT197 A Rare Case Of Infected Parathyroid Cyst Associated With Hyperparathyroidism
Journal of the Endocrine Society
2023 - ODP621 Hypertension with Hypokalemia in Pregnancy? Think "Cushing's Syndrome"
Journal of the Endocrine Society
2022
Similar KOLs
Other experts from the same institution or the same specialty.
John Reveille, MD
The University of Texas Health Science Center at Houston
Martin Citardi, MD
The University of Texas Health Science Center at Houston
Frank Arnett, MD
The University of Texas Health Science Center at Houston
Jerry Wolinsky, MD
The University of Texas Health Science Center at Houston
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”